These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23459048)
1. Editorial: Are thiopurines and anti-TNFα agents safe to use in pregnant patients with inflammatory bowel disease? Sheibani S; Mahadevan U Am J Gastroenterol; 2013 Mar; 108(3):441-3. PubMed ID: 23459048 [TBL] [Abstract][Full Text] [Related]
2. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Casanova MJ; Chaparro M; Domènech E; Barreiro-de Acosta M; Bermejo F; Iglesias E; Gomollón F; Rodrigo L; Calvet X; Esteve M; García-Planella E; García-López S; Taxonera C; Calvo M; López M; Ginard D; Gómez-García M; Garrido E; Pérez-Calle JL; Beltrán B; Piqueras M; Saro C; Botella B; Dueñas C; Ponferrada A; Mañosa M; García-Sánchez V; Maté J; Gisbert JP Am J Gastroenterol; 2013 Mar; 108(3):433-40. PubMed ID: 23318480 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis. Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092 [TBL] [Abstract][Full Text] [Related]
4. Effects and treatment of inflammatory bowel disease during pregnancy. Brar H; Einarson A Can Fam Physician; 2008 Jul; 54(7):981-3. PubMed ID: 18625819 [TBL] [Abstract][Full Text] [Related]
5. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984 [TBL] [Abstract][Full Text] [Related]
6. Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease? Brennan GT; Duong A; Nguyen ET; Nguyen DL Cleve Clin J Med; 2018 Dec; 85(12):923-924. PubMed ID: 30526752 [No Abstract] [Full Text] [Related]
7. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Akbari M; Shah S; Velayos FS; Mahadevan U; Cheifetz AS Inflamm Bowel Dis; 2013 Jan; 19(1):15-22. PubMed ID: 22434610 [TBL] [Abstract][Full Text] [Related]
8. Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease. Stobaugh DJ; Deepak P Ann Pharmacother; 2014 Oct; 48(10):1282-7. PubMed ID: 24982311 [TBL] [Abstract][Full Text] [Related]
9. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771 [TBL] [Abstract][Full Text] [Related]
10. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. Hutson JR; Matlow JN; Moretti ME; Koren G J Obstet Gynaecol; 2013 Jan; 33(1):1-8. PubMed ID: 23259868 [TBL] [Abstract][Full Text] [Related]
11. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease. Marion JF Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219 [No Abstract] [Full Text] [Related]
12. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
13. Table: safety of drugs for IBD in pregnancy. Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355 [No Abstract] [Full Text] [Related]
14. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Wieringa JW; Driessen GJ; Van Der Woude CJ Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):811-818. PubMed ID: 29972674 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. Chaparro M; Verreth A; Lobaton T; Gravito-Soares E; Julsgaard M; Savarino E; Magro F; Biron AI; Lopez-Serrano P; Casanova MJ; Gompertz M; Vitor S; Arroyo M; Pugliese D; Zabana Y; Vicente R; Aguas M; Shitrit BA; Gutierrez A; Doherty GA; Fernandez-Salazar L; Cadilla MJ; Huguet JM; OʼToole A; Stasi E; Marcos MN; Villoria A; Karmiris K; Rahier JF; Rodriguez C; Palomares DM; Fiorino G; Benitez JM; Principi M; Naftali T; Taxonera C; Mantzaris G; Sebkova L; Iade B; Lissner D; Bradley FI; Roman LA; Marin-Jimenez I; Merino O; Sierra M; Van Domselaar M; Caprioli F; Guerra I; Peixe P; Piqueras M; Rodriguez-Lago I; Ber Y; van Hoeve K; Torres P; Gravito-Soares M; Rudbeck-Resdal D; Bartolo O; Peixoto A; Martin G; Armuzzi A; Garre A; Donday MG; de Carpi MFJ; Gisbert JP Am J Gastroenterol; 2018 Mar; 113(3):396-403. PubMed ID: 29460920 [TBL] [Abstract][Full Text] [Related]
16. A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact. Roseira J; Ramos J Acta Med Port; 2019 Apr; 32(4):305-312. PubMed ID: 31067425 [TBL] [Abstract][Full Text] [Related]
17. Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child? de Boer NK; de Meij T; van Bodegraven AA Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):669-71. PubMed ID: 24134152 [No Abstract] [Full Text] [Related]
18. Lymphoma: the bête noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease. Beaugerie L Gastroenterology; 2013 Nov; 145(5):927-30. PubMed ID: 24070724 [No Abstract] [Full Text] [Related]
19. Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis. Zhang Y; Li D; Guo H; Wang W; Li X; Shen S Curr Pharm Des; 2021; 27(19):2317-2324. PubMed ID: 32938343 [TBL] [Abstract][Full Text] [Related]
20. Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapy. Greveson K; Goodhand J; Capocci S; Woodward S; Murray C; Cropley I; Hamilton M; Lipman M J Crohns Colitis; 2013 Jun; 7(5):412-8. PubMed ID: 23009739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]